Stocks · Korea
032300
KOSDAQ
Korea Pharma
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+22.86%
1M+17.27%
3M+10.80%
6M-22.29%
1Y-36.94%
YTD-32.26%
52W high14,950원
52W low6,350원
From 52W high-39.60%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 810억 | 62억 | -11억 | 7.6% |
| 2023 | 832억 | 63억 | 83,763,705원 | 7.5% |
| 2024 | 813억 | 61억 | 38억 | 7.5% |
| 2025 | 876억 | -9억 | -26억 | -1.0% |
| Quarterly | ||||
| 2024 4Q | 219억 | 19억 | 56,157,947원 | 8.8% |
| 2025 1Q | 208억 | 8억 | 5억 | 4.0% |
| 2025 2Q | 234억 | 82,574,531원 | -4억 | 0.3% |
| 2025 3Q | 240억 | 5억 | -20,902,803원 | 2.1% |
| 2025 4Q | 194억 | -23억 | -28억 | -11.9% |
| 2026 1Q | 246억 | 13억 | 7억 | 5.3% |
Company
Address: 경기도 화성시 향남읍 제약공단3길 87
Peers in the same sector
Recent filings
- 2026-10-02주요사항보고서(자기주식취득신탁계약체결결정) Major
- 2026-08-13반기보고서 (2026.06)
- 2026-05-20주요사항보고서(전환사채권발행결정) Major
- 2026-05-15분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.